Sodium-Glucose Cotransporter-2 Inhibitors at Discharge from Cardiology Hospitalization Department: Decoding A New Clinical Scenario

Sodium-glucose cotransporter-2 inhibitors (SGLT-2 inhibitors) are new glucose-lowering drugs (GLDs) with demonstrated cardiovascular benefits in patients with heart disease and type-2 diabetes mellitus (T2DM). However, their safety and efficacy when prescribed at hospital discharge are unexplored. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozado, José, García Iglesias, Daniel, Soroa, Miguel, Junco-Vicente, Alejandro, Barja, Noemí, Adeba, Antonio, Vigil-Escalera, María, Alvarez, Rut, Torres Saura, Francisco, Capín, Esmeralda, García, Laura, Rodriguez, María Luisa, Calvo, David, Moris, Cesar, Delgado, Elías, de la Hera, Jesús María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464502/
https://www.ncbi.nlm.nih.gov/pubmed/32796615
http://dx.doi.org/10.3390/jcm9082600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464502/
https://www.ncbi.nlm.nih.gov/pubmed/32796615
http://dx.doi.org/10.3390/jcm9082600

Ejemplares similares